跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Actemra - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Actemra
Approved
STANDARD
Actemra
Chugai Pharma Manufacturing Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1dc8ea89f880717c
Company
Chugai Pharma Manufacturing Co., Ltd.
Type
Standard
Approval Details
Approval Id
1dc8ea89f880717c
Drug Approval Philippines Name
Actemra
Product Name
Actemra
Registration Number
BR-689
Brand Name
Actemra
Generic Name
Tocilizumab
Dosage Form
Concentrate For Solution For I.V. Infusion
Dosage Strength
400 mg/ 20 mL
Manufacturer
Chugai Pharma Manufacturing Co., Ltd.
Importer
Roche (Philippines) Inc.
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/chugai-pharma-manufacturing-co-ltd
Issuance Date
10 April 2023
Expiry Date
20 March 2028
Pharmacologic Category
Interleukin Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1dc8ea89f880717c
Type
Standard
Back to Philippines FDA Approvals